Due to the COVID-19 pandemic we are facing a dramatic paradigm shift in Pharma Commercial Models. Digital is becoming a key part of the new paradigm and data-driven insights are a strategic pillar for reaching customer and stakeholders with the right message at the right time through the right channels and for improving performance and efficiency. This new approach requires an important cultural and organisational shift.
- HCP habits and needs have changed
- Adoption of digital channels has increased and new real-world insights that are there to understand our customers
- Advanced and dynamic segmentation and recommender systems enabled by artificial intelligence are needed
- Merck has performed various projects adopting this new approach that will be displayed during the presentation